METABOLIC AND MICROBIAL BIOMARKERS FOR DETECTION OF PANCREATICOBILIARY CANCERS
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Nov 21, 2024
app pub date -
May 20, 2024
filing date -
May 20, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Provided herein are biomarkers associated with pancreaticobiliary cancers. In particular, provided herein are metabolic, microbial, and/or glycomic biomarkers that, when measured in biological fluids (e.g., bile, serum, etc.) can be used to differentiate between pancreaticobiliary cancers and benign or other non-disease states.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully